Following years of research by Dr Joseph Cheriyan, Prof Ian Wilkinson, Dr James Rudd, and many others, GlaxoSmithKline (GSK) has announced a new Phase III clinical trial – LATITUDE-TIMI 60 – to test a new losmapimod drug in more than 25,000 patients with acute coronary syndrome. 

For more information please click on the links below:

https://clinicaltrials.gov/show/NCT02145468

http://www.cardiovascular.cam.ac.uk/news/losmapimod-phase-III-clinical-trial